Ultragenyx Pharmaceutical Inc. (RARE)

Ultragenyx Pharmaceutical Revenue

Ultragenyx Pharmaceutical had revenue of $136.00M in the quarter ending March 31, 2026, a decrease of -2.16%. This brings the company's revenue in the last twelve months to $669.71M, up 13.48% year-over-year. In the year 2025, Ultragenyx Pharmaceutical had annual revenue of $673.00M with 20.18% growth.

• Revenue (ttm): $669.71M
• Revenue Growth: +13.48%
• P/S Ratio: 3.66
• Revenue / Employee: $488,694
• Employees: 1,371
• Market Cap: 2.45B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	673.00M	113.00M	20.18%
Dec 31, 2024	560.00M	126.00M	29.03%
Dec 31, 2023	434.00M	70.67M	19.45%
Dec 31, 2022	363.33M	11.92M	3.39%
Dec 31, 2021	351.41M	80.38M	29.66%
Dec 31, 2020	271.03M	167.32M	161.32%
Dec 31, 2019	103.71M	52.22M	101.41%
Dec 31, 2018	51.50M	48.88M	1,871.48%
Dec 31, 2017	2.61M	2.48M	1,863.91%
Dec 31, 2016	133.00K	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-
Dec 31, 2011	-	-	-

Data Source: Fiscal.ai Last updated: May 5, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 11, 2026

Data Sources Report a data error